Dare Historical Cash Flow
| DARE Stock | USD 2.40 0.02 0.84% |
Analysis of Dare Bioscience cash flow over time is an excellent tool to project Dare Bioscience future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 40.2 K or Other Non Cash Items of 1.2 M as it is a great indicator of Dare Bioscience ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Dare Bioscience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dare Bioscience is a good buy for the upcoming year.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. About Dare Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Dare balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Dare's non-liquid assets can be easily converted into cash.
Dare Bioscience Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Dare Bioscience to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Dare Bioscience operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Dare Bioscience's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Dare Bioscience current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.At present, Dare Bioscience's Change In Working Capital is projected to increase significantly based on the last few years of reporting. The current year's Capital Expenditures is expected to grow to about 601.7 K, whereas Other Cashflows From Financing Activities is projected to grow to (2.1 K).
Dare Bioscience cash flow statement Correlations
Click cells to compare fundamentals
Dare Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dare Bioscience cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Free Cash Flow | (25.3M) | (28.8M) | (18.2M) | (39.5M) | 4.8M | 5.1M | |
| Change In Working Capital | 1.5M | 8.7M | 10.7M | (11.3M) | 5.8M | 6.1M | |
| Total Cashflows From Investing Activities | (17.6K) | (14.5K) | (63.1K) | (629.4K) | (573.0K) | (544.4K) | |
| Other Cashflows From Financing Activities | 9.0M | 532.7K | 124.6K | 6.0M | (2.2K) | (2.1K) | |
| Depreciation | 43.2K | 26.4K | 24.2K | 38.4K | 42.3K | 40.2K | |
| Other Non Cash Items | (162.2K) | (51.8K) | (23.1K) | 78.3K | 1.4M | 1.2M | |
| Total Cash From Operating Activities | (25.2M) | (28.8M) | (18.1M) | (38.9M) | 5.4M | 5.7M | |
| Change To Account Receivables | 95.0K | (685.1K) | (557.8K) | 753.9K | 719.2K | 755.2K | |
| Net Income | (27.4M) | (38.7M) | (30.9M) | (30.2M) | (4.1M) | (4.3M) | |
| Total Cash From Financing Activities | 25.1M | 75.8M | 1.3M | 15.6M | 433.8K | 412.1K | |
| End Period Cash Flow | 4.7M | 51.7M | 34.7M | 10.8M | 16.0M | 19.2M | |
| Change In Cash | (110.6K) | 47.0M | (17.0M) | (23.9M) | 5.2M | 5.4M | |
| Stock Based Compensation | 742.0K | 1.6M | 2.2M | 2.5M | 2.2M | 1.4M | |
| Begin Period Cash Flow | 4.8M | 4.7M | 51.7M | 34.7M | 10.8M | 17.6M | |
| Investments | (17.6K) | (14.5K) | (63.1K) | (24.8K) | (573.0K) | (544.4K) | |
| Change To Operating Activities | 220.1K | 537.1K | 964.7K | (647.3K) | (744.4K) | (707.2K) | |
| Other Cashflows From Investing Activities | (507K) | 6.1M | (925M) | (572.5M) | (515.2M) | (489.5M) | |
| Change To Netincome | 5.8M | 260.1K | 579.9K | 1.2M | 1.1M | 1.0M | |
| Issuance Of Capital Stock | 23.0M | 75.3M | 1.2M | 8.6M | 453.6K | 430.9K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Dare Bioscience is a strong investment it is important to analyze Dare Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Dare Bioscience's future performance. For an informed investment choice regarding Dare Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.17) | Revenue Per Share | Quarterly Revenue Growth 1.734 | Return On Assets | Return On Equity |
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.